SMTL ID : 5hd7.1

Dissecting Therapeutic Resistance to ERK Inhibition Rat Mutant SCH772984 in complex with (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

monomer

Ligands

1 x 38Z: (3R)-1-(2-oxo-2-{4-[4-(pyrimidin-2-yl)phenyl]piperazin-1-yl}ethyl)-N-[3-(pyridin-4-yl)-2H-indazol-5-yl]pyrrolidine-3-carboxamide(Non-covalent)

38Z.1: 28 residues within 4Å: Chain A: I.36, A.40, Y.41, V.44, A.57, K.59, I.61, S.62, P.63, Y.69, R.72, T.73, E.76, I.89, I.108, Q.110, D.111, L.112, M.113, E.114, T.115, D.116, K.119, L.161, C.171, D.172, F.173, D.174 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:I.36, A:Y.41, A:A.57, A:K.59, A:I.61, A:Y.69, A:Y.69, A:Y.69, A:Q.110 Hydrogen bonds: A:K.59, A:D.111, A:M.113, A:M.113, A:K.119 Water bridges: A:D.172 Salt bridges: A:E.76, A:D.172 pi-Stacking: A:Y.69

5 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 7 residues within 4Å: Chain A: R.75, R.177, V.178, D.337, M.338, E.339, L.340 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:V.178, A:D.337, A:M.338, A:E.339 Salt bridges: A:R.75, A:R.177 SO4.3: 4 residues within 4Å: Chain A: P.333, F.334, K.335, F.336 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.335, A:F.336, A:F.336 Salt bridges: A:K.335 SO4.4: 4 residues within 4Å: Chain A: R.153, L.175, R.177, V.193 5 PLIP interactions: 5 interactions with chain A Water bridges: A:R.153, A:V.193, A:V.193 Salt bridges: A:R.153, A:R.177 SO4.5: 4 residues within 4Å: Chain A: Y.192, R.196, R.199, Y.238 4 PLIP interactions: 4 interactions with chain A Water bridges: A:Y.238, A:Y.238 Salt bridges: A:R.196, A:R.199 SO4.6: 2 residues within 4Å: Chain A: G.187, K.264 6 PLIP interactions: 6 interactions with chain A Water bridges: A:G.187, A:G.187, A:G.187, A:K.264, A:K.264 Salt bridges: A:K.264

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jha, S. et al., Dissecting Therapeutic Resistance to ERK Inhibition. Mol.Cancer Ther. (2016)

Release Date

2016-02-24

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1